AIMECS 09--Seventh AFMC International Medicinal Chemistry Congress. 23-27 August 2009, Cairns, Queensland, Australia.
The Seventh Asian Federation for Medicinal Chemistry (AFMC) International Medicinal Chemistry Congress (AIMECS) held in Cairns, Australia was co-hosted by the Royal Australian Chemical Institute Division of Biomolecular Chemistry and included topics covering new therapeutic developments in the fields of cancer, cardiovascular disease, anti-infectives and CNS disorders. This conference report highlights selected presentations on anticancer agents, including ALK5 inhibitors, PAR1 inhibitors, anticoagulants, iron chelators, anxiolytics and GABA receptor antagonists. Investigational drugs discussed include IN-1130 (SK Chemicals Co Ltd/In2Gen Co), SCH-530348 (Schering-Plough Corp), apixaban (Bristol-Myers Squibb Co/Pfizer Inc) and BNC-210 (Bionomics Ltd).
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. danny.chan@thomsonreuters.com
Danny
D
Chan
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D044466:Asian People; D001315:Australia; D002626:Chemistry, Pharmaceutical / Q000639:trends*; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D038622:Internationality
D000970:Antineoplastic Agents